AC

Accendra Health, Inc.

ACHHealthcareNASDAQ

Medical Distribution · Last scanned Oct 24, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$2.76B
+3.1% YoY
Net Income
-$1.10B
-203.5% YoY
EBITDA
$219.8M
+635.5% YoY
Free Cash Flow
$420.2M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▲ RSI OversoldRSI 4.7, below 30, stock may be oversold
Oct 19▲ RSI OversoldRSI 4.4, below 30, stock may be oversold
About Accendra Health, Inc.

Part of the healthcare sector, Accendra Health, Inc. (ACH) is listed under Medical Distribution. Valued at $16.7M, ACH is a micro-cap name in its sector. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services.

Where ACH stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, ACH finished 90.56% below its 150-day moving average ($2.33) and 90.56% below its 200-day moving average ($2.33). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ACH overbought or oversold?

At the October 20, 2026 close, ACH's RSI(14) was 4.7, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$16.7M
Fwd P/E2.55
EPS$-1.48
Beta1.57
52W Change-96.0%
Dividend Yield0.00%
Analysis

The company holds $7.7M in cash, though total debt stands at $1.82B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $420.2M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROA of 0.6% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $9.96B to $2.76B.

Accendra Health, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. Accendra Health, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Accendra Health, Inc.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms